Enzo Life Sciences' Mito-ID assays work together to assess the dynamic interaction between mitochondrial respiration and glycolytic flux.
The Chemilum de Lys HDAC/SIRT Chemiluminescent Drug Discovery Kit enables reproducible, high-throughput screening of HDAC or SIRT inhibitors using a novel substrate that closely mimics the natural in vivo substrate.
The Amp'd GLP-1 ELISA kit, from Enzo Life Sciences, enables the ability to use less sample to detect levels of human Glucagon-like peptide 1 (7-36) amide: a potent promoter of insulin secretion which is a major incretin hormone and therapeutic for type 2 diabetes.
Enzo Life Sciences has introduced a novel line of conformational ELISA kits providing a sensitive, systematic and robust measurement of biosimilar conformation comparability at the molecular level. The kit allows for 3D conformational comparison and higher-order structure (HOS) characterisation between biosimilars and marketed MAbs.
Advanced Cell Diagnostics RNAscope LS ISH assays and Leica Biosystems Bond RX research staining platform19 August, 2014
Advanced Cell Diagnostics' RNAscope LS ISH assays are being marketed alongside Leica Biosystems' Bond RX research staining platform, providing researchers with an integrated and fully automated ISH solution.
Chemists from Oregon State University (OSU) have created a simple, inexpensive assay which can tell whether or not one of the primary drugs being used to treat malaria is genuine.
The cortisol ELISA kit from Enzo Life Sciences can be used with a large variety of sample types and produces highly reproducible results for stress, autoimmune disease and cancer research.
Qiagen's artus CMV RGQ MDx Kit for human cytomegalovirus (CMV) has been approved by the US Food and Drug Administration (FDA) under a full premarket approval (PMA). The PCR-based assay is optimised for low- to mid-throughput testing of CMV.
The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNVs) in patients referred for chromosomal testing. It is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
NT-proBNP brain natriuretic peptide, a member of the cardiac natriuretic hormones (CNHs) family, is secreted by the hemodynamically stressed heart, mainly in response to myocardial stretch induced by volume overload. The NT-proBNP ELISA from Biomedica provides reproducible results with an easy-to-use, convenient 96-well protocol (5 standards, 1 control).
Enzo Life Sciences has introduced an ELISA kit to quantify trefoil factor 1 in a wide variety of sample types - including bronchoalveolar lavage fluid, plasma or serum - for immunity and inflammation research.
Qiagen plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated infections (HAIs). The company's first new test, the artus C. difficile QS-RGQ MDx Kit, has been submitted to the US Food and Drug Administration (FDA).
CellDirector cell-based assays are microscale tools for live imaging and analysis of cell migration and behaviour in response to stable chemotactic concentration gradients. The CellDirector 2D assay can be used to study the chemotactic effect of any soluble substance on any type of adherent cell.
Designed for the SpectraMax i3 and Paradigm Multi-Mode Detection Platforms, the ScanLater Western Blot Detection Cartridge adds western blot detection capability to a microplate reader. This option allows researchers to do everything from protein detection via western blot to ELISAs on a single detection platform.
Enzo Life Sciences has expanded its portfolio of Wnt Pathway assays with the Leading Light Sclerostin-LRP Screening System. The simple, rapid biochemical binding assay format does not require cell lines or transfection reagents.